Anti-Estrogen Steroids Fulvestrant 129453-61-8 For Cancer Treatment

Create: 06/27/2018

Expired Date:	never
Category:	Butylated hydroxyanisole [Chemical]
Message:	Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor. It is administered as a once-monthly injection.





City:	Beijing Beijing[CN]
Location:

Mar 07 2019	Testosterone Acetate Trenbolone Powder CAS 10161-34-9 For Bodybuilding Muscle Growth	442
Jun 27 2018	Evodia rutaecarpa	544
Jun 27 2018	Okra extract	505
Jun 27 2018	Dodder Seed P.E.(Cuscuta chinensis P.E.)	511
Jun 27 2018	Songaria cynomorium herb P.E	525
Jun 27 2018	Cistanche deserticola	546
Jun 27 2018	Eurycoma longifolia Jack	528
Jun 27 2018	Damiana	522
Jun 27 2018	Morinda Officinalis	513
Jun 27 2018	Wolfberry Powder Extract	518